Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen-Reference-Cited by-同舟云学术

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Published:2007-01-30 Issue:3 Volume:21 Page:325-333
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Fischl Margaret A,Collier Ann C,Mukherjee A Lisa,Feinberg Judith E,Demeter Lisa M,Tebas Pablo,Giuliano Marina,Dehlinger Marjorie,Garren Kevin,Brizz Barbara,Bassett Roland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection;Palella;N Engl J Med,1998

2. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy;Gulick;N Engl J Med,1997

3. A controlled trial of two nucleoside analogues plus indinavir in person with human immunodeficiency virus infection and CD4 cell count of 200 cubic millimeter or less;Hammer;N Engl J Med,1997

4. A randomized trial comparing 2 different 4-drug antiretroviral regimens versus a 3-drug regimen in advanced HIV disease;Fischl;J Infect Dis,2003

5. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults;Staszewski;N Engl J Med,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2);Journal of Antimicrobial Chemotherapy;2020-03-04

2. Emergence of dual antiretroviral therapy as a viable regimen option for the treatment of patients with HIV infection;Drugs of Today;2020

3. Simplifying HAART: the Role of Two-Drug Therapy;Current Treatment Options in Infectious Diseases;2017-05-06

4. NRTI Sparing Therapy in Virologically Controlled HIV-1 Infected Subjects;JAIDS Journal of Acquired Immune Deficiency Syndromes;2016-05-01

5. Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients;PLOS ONE;2016-02-05